← back to search

Miguel Reina‐Campos

La Jolla Institute for Immunology ·
Area of research
Immunology · Molecular Biology
Research interest
Research interests include Immune Cell Function and Interaction, T-cell and B-cell Immunology, Cancer, Hypoxia, and Metabolism, and Epigenetics and DNA Methylation.
h-index
25
citations
3,772
works
37
NIH funding
primary concept
email

Recent publications

Tissue-resident memory CD8 T cell diversity is spatiotemporally imprinted
Nature 2025cited by 67position: firstdoi
The XCL1–XCR1 axis supports intestinal tissue residency and antitumor immunity
The Journal of Experimental Medicine 2025cited by 14position: middledoi
CRISPR screens unveil nutrient-dependent lysosomal and mitochondrial nodes impacting intestinal tissue-resident memory CD8+ T cell formation
Immunity 2024cited by 21position: middledoi
Increased translation driven by non-canonical EZH2 creates a synthetic vulnerability in enzalutamide-resistant prostate cancer
Nature Communications 2024cited by 12position: middledoi
Metabolic programs of T cell tissue residency empower tumour immunity
Nature 2023cited by 121position: firstdoi
Enhanced SREBP2-driven cholesterol biosynthesis by PKCλ/ι deficiency in intestinal epithelial cells promotes aggressive serrated tumorigenesis
Nature Communications 2023cited by 29position: middledoi
The lactate-NAD+ axis activates cancer-associated fibroblasts by downregulating p62
Cell Reports 2022cited by 66position: middledoi
CD8+ T cell metabolism in infection and cancer
Nature reviews. Immunology 2021cited by 597position: firstdoi
Supporting the Next Generation of Scientists to Lead Cancer Immunology Research
Cancer Immunology Research 2021cited by 1position: middledoi
Stromal SOX2 Upregulation Promotes Tumorigenesis through the Generation of a SFRP1/2-Expressing Cancer-Associated Fibroblast Population
Developmental Cell 2020cited by 125position: middledoi
Delineation of a molecularly distinct terminally differentiated memory CD8 T cell population
Proceedings of the National Academy of Sciences 2020cited by 117position: middledoi
NRF2 activates growth factor genes and downstream AKT signaling to induce mouse and human hepatomegaly
Journal of Hepatology 2020cited by 107position: middledoi
Increased Serine and One-Carbon Pathway Metabolism by PKCλ/ι Deficiency Promotes Neuroendocrine Prostate Cancer
Cancer Cell 2019cited by 181position: firstdoi
ATF4-Induced Metabolic Reprograming Is a Synthetic Vulnerability of the p62-Deficient Tumor Stroma
Cell Metabolism 2017cited by 112position: middledoi
p62, Upregulated during Preneoplasia, Induces Hepatocellular Carcinogenesis by Maintaining Survival of Stressed HCC-Initiating Cells
Cancer Cell 2016cited by 455position: middledoi
p62/SQSTM1 by Binding to Vitamin D Receptor Inhibits Hepatic Stellate Cell Activity, Fibrosis, and Liver Cancer
Cancer Cell 2016cited by 248position: middledoi
Metabolic Reprogramming of Stromal Fibroblasts through p62-mTORC1 Signaling Promotes Inflammation and Tumorigenesis
Cancer Cell 2014cited by 312position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ángeles Durán · Cornell University9 papers (2014–2024)María T. Díaz‐Meco · Cornell University9 papers (2014–2024)Jorge Moscat · Cornell University9 papers (2014–2024)Juan F. Linares · Cornell University6 papers (2016–2024)Ananda W. Goldrath · La Jolla Institute for Immunology6 papers (2020–2025)Christian M. Metallo · Salk Institute for Biological Studies4 papers (2014–2022)Maximilian Heeg · La Jolla Institute for Immunology3 papers (2023–2025)Nicole E. Scharping · University of California San Diego3 papers (2021–2025)John T. Chang · Ajinomoto (Japan)3 papers (2020–2025)Brigid S. Boland · Polish Academy of Sciences3 papers (2020–2025)Thekla Cordes · University of Luxembourg3 papers (2017–2022)Michael Karin · Discovery Institute3 papers (2016–2020) · 3 papers (2014–2017)Sindhu Raghunandan · University of California San Diego2 papers (2016–2016)Giovanni Galletti · University of California San Diego2 papers (2023–2025)Tania Cid-Diaz · Cornell University2 papers (2022–2024)Hongbo Chi · Taizhou University2 papers (2023–2024)Christopher S. Ahn · University of California San Diego2 papers (2014–2017) · 2 papers (2014–2017)Feng He · Shanghai University of Traditional Chinese Medicine2 papers (2016–2020)